Research and Markets: Research Report: Orphan Drugs for Cancer Pipeline Analysis

DUBLIN--()--Research and Markets (http://www.researchandmarkets.com/research/vpkfwg/orphan_drugs_for) has announced the addition of the "Orphan Drugs for Cancer Pipeline Analysis" report to their offering.

A huge market opportunity is offered by small patient population which suffers from rare or orphan diseases. Among the category of new orphan drugs, Oncology account for the largest disease group in recent years. It has been observed that majority of the orphan drugs in the clinical stages are for rare cancer disease drugs, and are in the late stages of the pipeline. Some of the drugs are being developed for treating rare cancer diseases like solid tumor of the pancreas and thyroid, blood cancer, melanoma, and others.

Orphan Drugs for Cancer Pipeline Analysis gives a comprehensive insight on the various orphan designated drugs being developed for the treatment of multiple cancers. Research report covers all the ongoing vaccines being developed in various development phases. This report enables pharmaceutical companies, collaborators and other associated stake holders to identify and analyze the available investment opportunity in the market for orphan designated cancer drugs based upon development process.

Following parameters for each orphan designated drug profile in development phase are covered in Orphan Drugs for Cancer Pipeline Analysis research report:

- Drug Profile Overview

- Alternate Names for Drug

- Active Indication

- Phase of Development

- Detailed Therapeutic Trials

- Mechanism of Action

- Brand Name

- Patent Information

- Orphan Designation by Indication, Country & Organisation

- Country for Clinical Trial

- Owner / Originator/ Licensee/Collaborator

- Administrative Route

- Drug Class

- ATC Codes

Orphan Designated Drugs for Cancer Treatment by Clinical Development Phase:

- Preclinical: 11

- Phase-I: 25

- Phase-I/II: 33

- Phase-II: 68

- Phase-II/III: 6

- Phase-III: 41

- Preregistration: 8

- Registered: 3

- Marketed: 59

For more information visit http://www.researchandmarkets.com/research/vpkfwg/orphan_drugs_for

About Research and Markets

Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Oncology

Sharing

Contacts

Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Pharmaceuticals, Oncology